Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae. - Wikidata - awgldk - TriplyDB

Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae.

Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae.

http://www.wikidata.org/entity/Q37363425

about

Susceptibility testing and reporting of new antibiotics with a focus on tedizolid: an international working group report.Use of Ancillary Carbapenemase Tests To Improve Specificity of Phenotypic Definitions for Carbapenemase-Producing Enterobacteriaceae.Carbapenem-resistant Enterobacteriaceae (CRE) detection practices in California: What are we missing?Minireview: CLSI Methods Development and Standardization Working Group Best Practices for the Evaluation of Antimicrobial Susceptibility Tests.Impact of 21st Century Cures Act on Breakpoints and Commercial Antimicrobial Susceptibility Test Systems: Progress and Pitfalls.The Case for Laboratory Developed Procedures: Quality and Positive Impact on Patient Care.

P2860

Q38641810-4BFFD2D3-DFE9-4221-A8B8-A00EC3A13BF0 Q45223236-46C1C92D-A487-413E-99A4-FE85E2CE5604 Q46330538-DA2F68BA-B6D6-4C2B-B7F6-0A77AA46D895 Q49789491-07D7562B-9677-4D62-9258-C278F54F3AC6 Q50048562-E06448E2-58FC-40D6-9374-61402A01E60E Q53108123-8A614D67-6DB4-4312-B42A-F74356AFDF5E

P2860

Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae.

http://www.wikidata.org/entity/Q37363425

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Impact of Delays between Clini ...... -Resistant Enterobacteriaceae.

@en

Impact of Delays between Clini ...... -Resistant Enterobacteriaceae.

@nl

type

label

Impact of Delays between Clini ...... -Resistant Enterobacteriaceae.

@en

Impact of Delays between Clini ...... -Resistant Enterobacteriaceae.

@nl

prefLabel

Impact of Delays between Clini ...... -Resistant Enterobacteriaceae.

@en

Impact of Delays between Clini ...... -Resistant Enterobacteriaceae.

@nl

P1433

Q37363425-14D2867A-B4B3-4C5A-889B-1142A3B6B60B

P1476

Q37363425-CF53C6E2-763E-4881-B591-59EA770BF2A8

P2093

Q37363425-1BCC9552-3210-4EEF-ABEB-2C0422C1F8A9

Q37363425-5E122435-CE41-4AB5-A51C-83B85564C21B

Q37363425-5E2DC6D5-23FC-46C6-8ED8-2ACB914053CC

Q37363425-67D278BC-5537-4EBB-BDC2-7EF21CE23F81

Q37363425-836DA059-71F4-465E-829A-8F09534B02F9

Q37363425-A0D4851A-BCBB-496D-8602-0FB27A74FF5F

Q37363425-A12457E3-112F-43BE-A708-64315E9CC132

Q37363425-B7FF4B66-3CEA-419C-B542-68A89AED59DB

P2860

Q37363425-09B37921-9751-4EE8-A8C6-2DB2DFAA236C

Q37363425-1B7B789A-73CF-4450-8F42-D630820024B6

Q37363425-39B9AECB-9C32-4927-8693-540FFB4F1120

Q37363425-3D60CE6D-644E-49DD-93C2-467ADADC80A6

Q37363425-4E01CFFC-89DC-4E59-BD32-B7AA1A408BC0

Q37363425-5125A9EB-78A5-4864-B14F-6EBD833AF06B

Q37363425-529F85D2-C529-479B-A24E-67E81C472A76

Q37363425-6BCD8813-65CB-43F2-A7AD-41D8F08A68EA

Q37363425-A2249DE7-F3FB-4006-9EB5-9B0B7D6E967C

Q37363425-A89FBB05-E3D1-44E8-8CC3-DC70FD5B919F

P304

Q37363425-8E63FA02-0597-4BF1-B78A-B7FA8DD8A74B

P31

Q37363425-F1045612-1EDA-45AF-B695-3034D372C1E5

P356

Q37363425-DEF85760-B407-4710-B253-3379EB5DF4D8

P407

Q37363425-43E6F2CF-7C23-4AB4-AD97-E6D33011FF0A

P433

Q37363425-CA61702E-3A01-4428-92EA-9563DB1BEEBE

P478

Q37363425-29BFC5B4-4871-4340-ADCC-62E907FFAF19

P50

Q37363425-8ECF23DE-7254-4DFC-A89E-4F8500118ABD

Q37363425-FD5FD674-69A0-4CA4-A71F-0326340534C1

P577

Q37363425-20CB2B46-7BCD-4938-A5EA-F74B4E76716D

P698

Q37363425-2461477C-0A0B-4AB0-9025-9654C512FD39

P921

Q37363425-A740779F-6F7F-4468-BC2E-D30D32EE4386

P932

Q37363425-083396D1-2AA2-44A3-8610-588BDB038317

P356

P1433

Journal of Clinical Microbiology

P1476

Impact of Delays between Clini ...... -Resistant Enterobacteriaceae.

@en

P2093

Daniel F Sahm

http://www.w3.org/2001/XMLSchema#string

James A McKinnell

http://www.w3.org/2001/XMLSchema#string

John A Jernigan

http://www.w3.org/2001/XMLSchema#string

Kim F Wong

http://www.w3.org/2001/XMLSchema#string

Krystyna Kazmierczak

http://www.w3.org/2001/XMLSchema#string

Leslie E Mueller

http://www.w3.org/2001/XMLSchema#string

Rachel B Slayton

http://www.w3.org/2001/XMLSchema#string

Susan S Huang

http://www.w3.org/2001/XMLSchema#string

P2860

The limits of serial surveillance cultures in predicting clearance of colonization with carbapenemase-producing Enterobacteriaceae.

Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013

Contact precautions for multidrug-resistant organisms: Current recommendations and actual practice.

Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs.

Comparative evaluation of a prototype chromogenic medium (ChromID CARBA) for detecting carbapenemase-producing Enterobacteriaceae in surveillance rectal swabs.

Rapid detection of carbapenemase-producing Enterobacteriaceae

Continuing Challenges for the Clinical Laboratory for Detection of Carbapenem-Resistant Enterobacteriaceae.

Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United States

The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.

The Regional Healthcare Ecosystem Analyst (RHEA): a simulation modeling tool to assist infectious disease control in a health system.

P304

2757-2762

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.00635-16

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Sarah M Bartsch

P577

2016-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27582516

http://www.w3.org/2001/XMLSchema#string

P921

carbapenem antibiotic

P932

5078554

http://www.w3.org/2001/XMLSchema#string